arrow
J

Jorge Blando

AstraZeneca
H指数:42
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Volrustomig a novel PD-1/CTLA-4 bispecific antibody leads to robust increase in peripheral and intra-tumoral pharmacodynamic biomarkers in solid tumors from FTiH study
2024-03-220
PRE
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

MEDI0680联合Durvalumab与Nivolumab单药治疗晚期或转移性透明细胞肾细胞癌患者的随机II期研究

2022-05-048
OAAI
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

聚乙二醇化精氨酸脱亚胺酶 (ADI-PEG 20) 联合Pembrolizumab治疗晚期实体癌的1b期研究

2021-07-1228
OAAI
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

顺铂不能手术的高危尿路上皮癌患者的新辅助PD-L1加CTLA-4阻滞

2020-10-12215
OAAI
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC

ARID1A突变加CXCL13表达可作为组合生物标志物预测mUCC对免疫检查点治疗的反应

2020-06-1790
PREAI
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

ipilimumab治疗前列腺癌患者后的新抗原反应,免疫相关性和有利结果

2020-04-01116
PREAI
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages

帕博利珠单抗在复发性胶质母细胞瘤患者中的机会之窗临床试验揭示了免疫抑制性巨噬细胞的优势

2019-11-22114
OAAI
Effector B cells and tertiary lymphoid structures predict response to immune checkpoint blockade in solid tumors
2019-07-010
PRE
NanoString® GeoMx® digital spatial profiling further defines the role of B cells in the response to immune checkpoint blockade
2019-07-010
PRE
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

阿扎胞苷和Nivolumab治疗复发/难治性急性髓系白血病的疗效、安全性和生物标志物: 一项非随机、开放标签、II期研究

2019-03-01417
OAAI
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer

黑色素瘤和胰腺癌中免疫浸润的比较突出了VISTA作为胰腺癌的潜在靶标

2019-01-11260
OA
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

初诊和复发急性髓系白血病患者T细胞亚群分布及免疫检查点受体和配体的表达

CANCER
IF5.1
2018-11-30243
OAAI
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis (vol 24, pg 1804, 2018)
2018-11-2717
OAAI
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

粪菌移植治疗难治性免疫检查点抑制剂相关性结肠炎

2018-11-12529
OAAI